Growth Hormone Secretagogue • Anti-Aging Therapy
Natural Growth Hormone Optimization
This synergistic peptide combination enhances your body’s natural growth hormone production through complementary pathways. CJC-1295 extends GH pulse duration while Ipamorelin amplifies pulse strength—together creating sustained, physiologic growth hormone elevation for muscle growth, fat loss, recovery, and anti-aging benefits.
2x
Synergistic Peptides
5-7x
Weekly Injections
24/7
Sustained GH Support
Zero
Cortisol or Prolactin Spike
Treatment Options
Our combined formulation delivers both peptides in precise ratios for optimal growth hormone enhancement with minimal side effects.
CJC-1295 2mg + Ipamorelin 2mg
Ideal For
Beginners seeking natural growth hormone optimization, improved recovery, and anti-aging benefits with a well-tolerated starting dose.
CJC-1295 5mg + Ipamorelin 5mg
Ideal For
Experienced users seeking maximum growth hormone support for serious body composition goals, athletic performance, or comprehensive anti-aging.
The Science
This powerful combination pairs two complementary growth hormone secretagogues (GHS) that work together to naturally enhance your body’s GH production. Unlike synthetic growth hormone, these peptides stimulate your pituitary gland to release GH in a physiologic, pulsatile pattern.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue that extends the duration of GH pulses by preventing enzymatic degradation. Ipamorelin is a ghrelin mimetic that selectively stimulates GH release without affecting cortisol or prolactin levels—making it one of the cleanest GH secretagogues available.
Together, they create a synergistic effect: CJC-1295 prolongs each GH pulse while Ipamorelin amplifies its strength, resulting in sustained elevation of growth hormone throughout the day and night for optimal body composition, recovery, and longevity benefits.
Schedule Consultation
How It Works
CJC-1295 and Ipamorelin target different receptors to create sustained, amplified growth hormone secretion.
CJC-1295 binds to GHRH receptors in the pituitary, stimulating growth hormone release while resisting degradation for extended duration.
Ipamorelin activates ghrelin receptors to amplify GH pulse strength without the cortisol or prolactin spikes seen with other secretagogues.
Combined, these peptides create stronger, longer-lasting GH pulses than either compound alone—optimizing the body’s natural rhythm.
Elevated GH stimulates liver production of IGF-1, the primary mediator of growth hormone’s anabolic and metabolic benefits.
Treatment Comparison
Understanding the differences between growth hormone therapies helps you choose the right approach for your goals.
*Cost and side effect profiles are approximate and may vary based on individual response and dosing protocols.
Key Benefits
Enhanced protein synthesis and nitrogen retention support muscle growth and preservation, even during caloric restriction.
Growth hormone promotes lipolysis (fat breakdown) and shifts metabolism toward preferential use of fat for energy.
Enhanced tissue repair and reduced inflammation lead to quicker recovery from workouts, injuries, and daily stress.
GH secretion naturally peaks during deep sleep; optimizing levels can enhance sleep architecture and restorative rest.
Growth hormone supports collagen production, skin elasticity, and cellular regeneration for a more youthful appearance.
GH stimulates osteoblast activity and calcium retention, supporting bone mineral density and long-term skeletal health.
Getting Started
Starting CJC-1295 + Ipamorelin therapy is straightforward with our physician-guided protocol.
Meet with our physician to review your health history, goals, and candidacy for peptide therapy.
Comprehensive bloodwork measures baseline IGF-1, hormones, and metabolic markers to guide dosing.
Receive your peptides with detailed injection instructions and dosing protocol tailored to your needs.
Regular follow-ups monitor progress, adjust dosing, and ensure optimal results with minimal side effects.
Safety Profile
CJC-1295 and Ipamorelin are among the most studied and well-tolerated growth hormone secretagogues, with extensive research supporting their safety and efficacy.
20+
Years of clinical research on growth hormone secretagogues
95%+
Patient tolerability with minimal adverse effects
Questions
CJC-1295 + Ipamorelin stimulate your body’s natural GH production through the pituitary gland, maintaining physiologic pulsatile secretion. Synthetic GH (like HGH injections) provides exogenous hormone that can suppress natural production and carries higher risks of side effects. Peptide therapy is safer, more natural, and preserves your body’s regulatory feedback loops.
Most protocols involve subcutaneous injections 5-7 times per week, typically before bed to align with natural GH secretion patterns. Some physicians recommend twice-daily dosing for maximum results. Injections are simple, using a small insulin-type syringe, and most patients quickly become comfortable with the process.
Initial benefits like improved sleep quality and recovery can appear within 2-4 weeks. Body composition changes (muscle gain, fat loss) typically become noticeable around 8-12 weeks. Optimal results occur with consistent use over 3-6 months, as GH’s effects are cumulative and require time for tissue remodeling.
CJC-1295 + Ipamorelin are very well-tolerated. The most common side effects are mild: slight water retention, flushing, or injection site reactions. Unlike some GH secretagogues, Ipamorelin does not increase hunger, cortisol, or prolactin. Serious side effects are rare when used under physician supervision with appropriate dosing.
Yes. CJC-1295 + Ipamorelin pair well with testosterone replacement therapy (TRT), thyroid optimization, and other hormone therapies. Many patients combine peptide therapy with weight loss medications for enhanced body composition results. Your physician will create an integrated protocol tailored to your specific health goals.
Many patients use CJC-1295 + Ipamorelin long-term for anti-aging and performance benefits. Common approaches include continuous therapy, 5-days-on/2-days-off protocols, or cycling (e.g., 3-6 months on, 1-2 months off). Your physician will recommend a schedule based on your response, goals, and laboratory monitoring.
Peptide therapy for anti-aging, performance enhancement, and body composition is typically not covered by insurance. However, we offer competitive self-pay pricing and flexible treatment options. Some HSA/FSA accounts may reimburse peptide therapy—consult your plan administrator for specifics.
Ready to Start?
Optimize your growth hormone levels naturally with physician-supervised CJC-1295 + Ipamorelin therapy.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*IMPORTANT: CJC-1295 and Ipamorelin are prescription medications that must be obtained through a licensed physician. Results vary based on individual factors including age, baseline hormone levels, diet, exercise, and adherence to protocol. This page is for educational purposes only and does not constitute medical advice. All peptide therapy should be conducted under physician supervision with appropriate laboratory monitoring. Not all patients are candidates for growth hormone secretagogue therapy. Consult with our medical team to determine if this treatment is appropriate for your health status and goals.
These two peptides are paired because they work on the growth-hormone axis through different, complementary routes — CJC-1295 as a growth-hormone-releasing hormone analogue, Ipamorelin as a selective secretagogue. Used together they produce a more physiological release pattern than either alone, and crucially, they prompt your own pituitary rather than replacing its output.
Because this pairing prompts your own pituitary rather than supplying exogenous growth hormone, it retains the body’s regulatory feedback — which is the main reason it is generally preferred over direct HGH for the goals most patients have. For the full technical breakdown — dosing ranges, reconstitution math, syringe calculations and cycle structures — see our complete CJC-1295 & Ipamorelin dosage guide.
Book a CJC-1295 / Ipamorelin ConsultationResponse varies between individuals, and the timeline below reflects what patients on a supervised protocol commonly report rather than a guaranteed outcome. Your provider will set expectations specific to your labs, history and goals.
| Timeframe | What patients typically report |
|---|---|
| Weeks 1–2 | Sleep is almost always the first thing to change — deeper sleep and easier onset. This is the most consistently reported early effect. |
| Weeks 3–6 | Recovery between training sessions and general daytime energy commonly improve. Body-composition changes are not yet meaningful at this stage. |
| Weeks 6–12 | The window in which body-composition changes typically become apparent, and only alongside consistent training and adequate protein intake. The peptides do not substitute for either. |
| Weeks 12–24 | Follow-up IGF-1 and reassessment. Dose is adjusted to keep you in range, and the decision to continue or cycle off is made here. |
| After the cycle | Cycling off is standard practice. Whether to run another cycle depends on your follow-up labs and what actually changed. |
Patients often arrive comparing this pairing to direct HGH or to the individual components. The differences matter and are worth understanding before your consultation.
| Option | Primary use | Administration | Best suited to |
|---|---|---|---|
| CJC-1295 + Ipamorelin | Stimulates your own GH release, physiological pattern | Subcutaneous, nightly | Most patients seeking recovery, sleep and body composition |
| Ipamorelin alone | Selective GH secretagogue, gentler effect | Subcutaneous, nightly | Patients wanting a more conservative starting point |
| CJC-1295 alone | GHRH analogue | Subcutaneous | Rarely used alone; the pairing is generally more effective |
| Direct HGH | Exogenous growth hormone | Subcutaneous, daily | Diagnosed growth hormone deficiency, prescribed and closely managed |
| Tesamorelin | Targeted visceral fat reduction | Subcutaneous, daily | Patients with a specific visceral fat concern |
Direct HGH bypasses your body’s regulatory feedback entirely and carries a different risk and cost profile. For the goals most patients present with, the secretagogue pairing is the more appropriate starting point.
IGF-1 is the number that matters here. It is the most direct read on whether the protocol is doing what it is supposed to, and on whether you have gone past the point where benefit stops and risk begins.
If mid-cycle IGF-1 comes back above the appropriate range, the correct response is to reduce the dose, not to accept it as a sign the protocol is working. Higher is not better, and your provider will adjust accordingly.
They act on the growth-hormone axis through different, complementary routes — CJC-1295 as a GHRH analogue, Ipamorelin as a selective secretagogue. Combined, they produce a more physiological release pattern than either alone. Ipamorelin is also relatively selective, meaning less impact on cortisol and appetite than older secretagogues.
It matters more than almost anything else. Dosing is typically nightly on an empty stomach, to reinforce your natural overnight GH pulse. Eating close to the dose, particularly carbohydrate, blunts the release. Poor timing is the most common reason a protocol underdelivers.
HGH supplies growth hormone directly, bypassing your body’s regulatory feedback. This pairing prompts your own pituitary to release it, which preserves that feedback and generally produces a more physiological pattern. For the goals most patients have, the secretagogue approach is the more appropriate starting point — and typically less expensive.
Sleep quality usually improves within the first week or two and is the most consistent early signal. Recovery and energy follow across weeks three to six. Body-composition changes generally take two to three months and depend heavily on training and nutrition. Anyone promising dramatic change in month one is overselling.
Yes. BHRC prescribes and dispenses both peptides under provider supervision following consultation and baseline labs. We do not supply them as unsupervised products. Peptides sold online under ‘research use only’ labelling carry real sourcing, purity and legal risk.
Cost depends on your protocol, cycle length and required lab work. Pricing is reviewed transparently at consultation before anything is prescribed. Peptide therapy is generally not covered by insurance.
No. Neither is an FDA-approved drug. Both are accessed through compounding pharmacies and used off-label under provider supervision, which is why baseline and follow-up IGF-1 monitoring is treated as a requirement rather than an optional extra.
Most commonly reported are injection-site reactions, transient flushing or head-rush shortly after dosing, and vivid dreams. Fluid retention, joint discomfort or carpal-tunnel-type symptoms usually indicate dosing above the appropriate range and warrant a dose reduction — report them promptly.
Yes. Growth hormone secretagogues are prohibited under WADA and USADA and are detectable. If you compete in a tested sport, this is not an option, and you should verify current status against the governing list rather than relying on general guidance.
BHRC provides physician-supervised peptide therapy across its locations, including West Hollywood, West Los Angeles, Valencia, Paradise Valley and Summerlin. Consultation determines candidacy and protocol, with mid-cycle labs and follow-up handled through your treating location.
These are the therapies most often compared with this pairing, plus the guide covering full dosing and timing detail.
The literature below is peer-reviewed background on CJC-1295 / Ipamorelin and the mechanisms discussed on this page. It is provided so you can read the primary sources yourself. It is not evidence of any particular outcome at BHRC, and much of it is preclinical — animal or cell-culture work that has not been replicated in humans. Your provider will discuss what the evidence does and does not support for your situation.
